vs
Side-by-side financial comparison of ATLANTIC AMERICAN CORP (AAME) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $53.8M, roughly 1.2× ATLANTIC AMERICAN CORP). ATLANTIC AMERICAN CORP runs the higher net margin — 1.1% vs -70.9%, a 72.0% gap on every dollar of revenue. On growth, ATLANTIC AMERICAN CORP posted the faster year-over-year revenue change (20.8% vs 8.1%). ATLANTIC AMERICAN CORP produced more free cash flow last quarter ($6.6M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 7.2%).
The Atlantic Telegraph Company was a company formed on 6 November 1856 to undertake and exploit a commercial telegraph cable across the Atlantic Ocean, the first such telecommunications link.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
AAME vs CTKB — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $53.8M | $62.1M |
| Net Profit | $577.0K | $-44.1M |
| Gross Margin | — | 52.9% |
| Operating Margin | 1.4% | -9.0% |
| Net Margin | 1.1% | -70.9% |
| Revenue YoY | 20.8% | 8.1% |
| Net Profit YoY | 128.9% | -557.1% |
| EPS (diluted) | $0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $62.1M | ||
| Q3 25 | $53.8M | $52.3M | ||
| Q2 25 | $55.3M | $45.6M | ||
| Q1 25 | $50.1M | $41.5M | ||
| Q4 24 | $49.0M | $57.5M | ||
| Q3 24 | $44.5M | $51.5M | ||
| Q2 24 | $47.7M | $46.6M | ||
| Q1 24 | $47.0M | $44.9M |
| Q4 25 | — | $-44.1M | ||
| Q3 25 | $577.0K | $-5.5M | ||
| Q2 25 | $3.3M | $-5.6M | ||
| Q1 25 | $802.0K | $-11.4M | ||
| Q4 24 | $412.0K | $9.6M | ||
| Q3 24 | $-2.0M | $941.0K | ||
| Q2 24 | $-684.0K | $-10.4M | ||
| Q1 24 | $-2.0M | $-6.2M |
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 51.3% |
| Q4 25 | — | -9.0% | ||
| Q3 25 | 1.4% | -17.6% | ||
| Q2 25 | 7.6% | -23.3% | ||
| Q1 25 | 2.1% | -36.1% | ||
| Q4 24 | 1.1% | 5.2% | ||
| Q3 24 | -5.5% | -8.2% | ||
| Q2 24 | -1.8% | -18.3% | ||
| Q1 24 | -5.3% | -23.9% |
| Q4 25 | — | -70.9% | ||
| Q3 25 | 1.1% | -10.5% | ||
| Q2 25 | 6.0% | -12.2% | ||
| Q1 25 | 1.6% | -27.5% | ||
| Q4 24 | 0.8% | 16.8% | ||
| Q3 24 | -4.5% | 1.8% | ||
| Q2 24 | -1.4% | -22.4% | ||
| Q1 24 | -4.3% | -13.8% |
| Q4 25 | — | — | ||
| Q3 25 | $0.02 | — | ||
| Q2 25 | $0.15 | — | ||
| Q1 25 | $0.03 | — | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $-0.10 | — | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.10 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.4M | $90.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $109.5M | $341.7M |
| Total Assets | $430.9M | $461.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $90.9M | ||
| Q3 25 | $34.4M | $93.3M | ||
| Q2 25 | $46.4M | $75.5M | ||
| Q1 25 | $35.9M | $95.3M | ||
| Q4 24 | $35.6M | $98.7M | ||
| Q3 24 | $23.0M | $162.3M | ||
| Q2 24 | $21.2M | $177.9M | ||
| Q1 24 | $21.2M | $168.8M |
| Q4 25 | — | $341.7M | ||
| Q3 25 | $109.5M | $378.6M | ||
| Q2 25 | $106.2M | $377.6M | ||
| Q1 25 | $102.4M | $379.6M | ||
| Q4 24 | $99.6M | $395.7M | ||
| Q3 24 | $105.8M | $385.5M | ||
| Q2 24 | $100.7M | $389.1M | ||
| Q1 24 | $102.8M | $392.6M |
| Q4 25 | — | $461.5M | ||
| Q3 25 | $430.9M | $494.9M | ||
| Q2 25 | $429.3M | $493.3M | ||
| Q1 25 | $388.4M | $482.6M | ||
| Q4 24 | $393.4M | $499.5M | ||
| Q3 24 | $387.0M | $491.2M | ||
| Q2 24 | $386.0M | $483.7M | ||
| Q1 24 | $365.8M | $492.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.6M | $-771.0K |
| Free Cash FlowOCF − Capex | $6.6M | $-1.8M |
| FCF MarginFCF / Revenue | 12.3% | -2.9% |
| Capex IntensityCapex / Revenue | 0.1% | 1.6% |
| Cash ConversionOCF / Net Profit | 11.51× | — |
| TTM Free Cash FlowTrailing 4 quarters | $19.3M | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-771.0K | ||
| Q3 25 | $6.6M | $-3.9M | ||
| Q2 25 | $9.3M | $108.0K | ||
| Q1 25 | $-722.0K | $-125.0K | ||
| Q4 24 | $4.8M | $2.0M | ||
| Q3 24 | $90.0K | $13.2M | ||
| Q2 24 | $416.0K | $6.2M | ||
| Q1 24 | $-5.3M | $4.0M |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $6.6M | $-4.6M | ||
| Q2 25 | $9.1M | $-1.5M | ||
| Q1 25 | $-986.0K | $-974.0K | ||
| Q4 24 | $4.6M | $1.1M | ||
| Q3 24 | $58.0K | $12.2M | ||
| Q2 24 | $361.0K | $5.2M | ||
| Q1 24 | $-5.4M | $3.4M |
| Q4 25 | — | -2.9% | ||
| Q3 25 | 12.3% | -8.7% | ||
| Q2 25 | 16.5% | -3.2% | ||
| Q1 25 | -2.0% | -2.3% | ||
| Q4 24 | 9.3% | 1.9% | ||
| Q3 24 | 0.1% | 23.7% | ||
| Q2 24 | 0.8% | 11.0% | ||
| Q1 24 | -11.4% | 7.6% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | 0.1% | 1.3% | ||
| Q2 25 | 0.3% | 3.5% | ||
| Q1 25 | 0.5% | 2.0% | ||
| Q4 24 | 0.5% | 1.6% | ||
| Q3 24 | 0.1% | 2.0% | ||
| Q2 24 | 0.1% | 2.3% | ||
| Q1 24 | 0.1% | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | 11.51× | — | ||
| Q2 25 | 2.80× | — | ||
| Q1 25 | -0.90× | — | ||
| Q4 24 | 11.65× | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAME
| Bankers Fidelity | $30.0M | 56% |
| American Southern | $23.7M | 44% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
